Q) Poor prognostic feature for NSGCT (Non Seminomatous germ cell tumor)
A. Age more than 40 years
B. Mediastinal tumour
C. AFP level less than 10,000
D. Non Pulmonary visceral metastasis absent
6000+ High-Yield MCQs & Explanations – NEET SS MCH
Q) Poor prognostic feature for NSGCT (Non Seminomatous germ cell tumor)
A. Age more than 40 years
B. Mediastinal tumour
C. AFP level less than 10,000
D. Non Pulmonary visceral metastasis absent
Q) Regarding insulinoma, true is
a) Mostly malignant
b) Classic whipples triad seen in very few patients
Q) 50-year-old male with 1 x1 cm mass in the Peripheral part of the right lung was resected with clear margins. histopathology was suggestive of Adenocarcinoma and there was no lymph nodes positive what will be the further management
A. Observe
B. Adjuvant RT
C. Adjuvant CT
D. EGFR testing
Q ) Which of the following statement regarding yttrium 90 is incorrect: ( From Gen onco Surgery Q 21-40)
a. Used for brachytherapy
b. Is a pure beta emitter with range of 1 cm
c. Most commonly used for treatment of ca prostate
d. Used in treatment of both primary and metastatic liver cancer through hepatic artery embolization
Q) WHich of the following is not a histological feature of Crohn disease of the bowel
a) Stricture
b) Granuloma
c) Crypt Abscess
d) Goblet cell atrophy
Q) Not a significant factor for prognosis in colorectal metastasis?
a) Involved lymph node in primary
b) Metachronous lesion
c) Synchronous lesion
d) Size more than 5 cm
Q) Condylomata acuminatum false is
a. Treatment- podophylin, electrocautery etc
b. Most Common STD seen by Colo Rectal surgeons
c. Caused By HPV
d. MC seen as cancer
Q) Most common germ-cell tumor of mediastinum is?
A. Seminoma
B. NSGCT
C. Teratoma
D. Choriocarcinoma
Q) Role of cetuximab in CA colon is in
A. Wild type KRAS
B. KRAS MUTATION
C. Early ca colon
D. Stage 3 colon cancer
Q) Total Proctocolectomy is required for which of the following ? ( MCH GI Surgery Question- Click here for all)
a) Cowden
b) HNPCC
c) Gardner
d) PJS
Snippet -- HNPCC- Lynch syndrome patients develop colorectal and extracolonic cancers at a young age. It accounts for approximately 3% of all CRCs, and 10% to 19% of CRCs diagnosed before age 50. Read on..........